Short Interest in Arch Therapeutics, Inc. (OTCMKTS:ARTH) Increases By 22.1%

Arch Therapeutics, Inc. (OTCMKTS:ARTH) was the recipient of a large growth in short interest in March. As of March 31st, there was short interest totalling 14,900 shares, a growth of 22.1% from the March 15th total of 12,200 shares. Based on an average daily trading volume, of 1,800 shares, the short-interest ratio is presently 8.3 days. Currently, 0.3% of the shares of the stock are sold short.

Arch Therapeutics Stock Performance

ARTH stock opened at $0.20 on Friday. The firm’s 50-day moving average is $0.21 and its two-hundred day moving average is $0.23. Arch Therapeutics has a 52 week low of $0.16 and a 52 week high of $1.57.

About Arch Therapeutics

Arch Therapeutics, Inc, together with its subsidiaries, operates as a biotechnology company in the United States. It develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease.